Seilern Investment Management Ltd Has $46.01 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Seilern Investment Management Ltd raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 115,695 shares of the medical equipment provider’s stock after buying an additional 17,337 shares during the period. Intuitive Surgical comprises approximately 5.8% of Seilern Investment Management Ltd’s holdings, making the stock its 8th largest position. Seilern Investment Management Ltd’s holdings in Intuitive Surgical were worth $46,010,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Prosperity Consulting Group LLC increased its position in Intuitive Surgical by 0.5% during the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after acquiring an additional 19 shares during the last quarter. WoodTrust Financial Corp boosted its position in Intuitive Surgical by 0.5% in the fourth quarter. WoodTrust Financial Corp now owns 4,180 shares of the medical equipment provider’s stock worth $2,367,000 after purchasing an additional 20 shares during the last quarter. North Star Investment Management Corp. grew its stake in shares of Intuitive Surgical by 8.5% during the 4th quarter. North Star Investment Management Corp. now owns 269 shares of the medical equipment provider’s stock valued at $152,000 after purchasing an additional 21 shares during the period. Cornerstone Planning Group LLC grew its stake in shares of Intuitive Surgical by 11.5% during the 4th quarter. Cornerstone Planning Group LLC now owns 203 shares of the medical equipment provider’s stock valued at $106,000 after purchasing an additional 21 shares during the period. Finally, Valeo Financial Advisors LLC increased its position in shares of Intuitive Surgical by 0.4% during the 4th quarter. Valeo Financial Advisors LLC now owns 4,941 shares of the medical equipment provider’s stock valued at $2,798,000 after purchasing an additional 21 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00. Following the sale, the executive vice president directly owned 5,720 shares in the company, valued at $2,426,080.80. This trade represents a 6.54% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the transaction, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 6,634 shares of company stock valued at $2,796,795. Company insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on ISRG. Citigroup lowered their price objective on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a report on Friday, July 17th. Evercore set a $430.00 target price on shares of Intuitive Surgical in a report on Monday, July 6th. Royal Bank Of Canada dropped their price target on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating on the stock in a research note on Monday, July 13th. Finally, Leerink Partners cut their price objective on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a research report on Friday, July 17th. Twenty investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $509.02.

Intuitive Surgical Stock Up 1.4%

ISRG stock opened at $378.81 on Friday. The business’s 50-day moving average price is $392.87 and its 200-day moving average price is $445.78. The stock has a market cap of $133.83 billion, a P/E ratio of 43.39, a PEG ratio of 2.74 and a beta of 1.46. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. During the same period in the prior year, the firm posted $1.81 EPS. The firm’s quarterly revenue was up 18.4% compared to the same quarter last year. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.